India’s Obesity
Intelligence Layer
India is getting heavier.
The intelligence is still scattered.
If your business touches weight, food, fitness, metabolic health, diabetes, nutrition, wellness, or obesity treatment in India,
KOBI is your intelligence layer.
KOBI helps D2C health brands, pharma teams, and healthcare businesses understand how India thinks, buys, treats, avoids, and acts on obesity.
Explore Obesity Intelligence
Obesity in India is not one problem.
It is a food problem.
A family problem.
A stigma problem.
A repeat-purchase problem.
A business problem.
India cannot solve a fast-moving obesity market with slow, scattered understanding.
KOBI turns obesity from a statistic into decision-grade intelligence.
What KOBI Does
We decode India’s obesity decisions.
KOBI studies how Indians think about weight, health, nutrition, fitness, treatment, doctors, brands, creators, medicines, and quick fixes.
We help teams understand what people believe, what they buy, what they avoid, whom they trust, and why they drop off.
Consumer intelligence.
What Indians think, feel, buy, delay,
try, and abandon.
Clinical and therapy intelligence.
How patients, doctors, specialists,
and care teams view obesity treatment.
Market and brand intelligence.
How D2C, pharma, healthcare, and
wellness players can build sharper obesity strategies.
D2C Brands
For D2C health, nutrition, wellness, and weight-care brands.
You may know your product.
You may know your claim.
You may know your CAC.
But do you know how India decides around weight?
KOBI helps you understand the consumer before you launch, scale, reposition, or burn money on generic campaigns.
Use Cases
Claim testing.
Protein and supplement adoption.
Weight-care consumer segments.
Pricing and willingness to pay.
Repeat purchase and drop-off diagnosis.
For Pharma and Healthcare
Obesity treatment does not move only through prescriptions.
It moves through patient readiness, doctor confidence, family support, stigma, cost anxiety, side-effect fears, follow-up fatigue, and social media noise.
KOBI helps teams understand the real-world obesity journey in India.
Use Cases
Patient readiness.
GLP-1 awareness and hesitation.
Doctor-patient communication gaps.
Treatment drop-off.
Therapy adherence.
What KOBI Tracks
1) Weight concern.
2) Doctor consultation intent.
3) Propensity to try/buy.
4) D2C health product trust.
5) Protein and supplement behaviour.
6) GLP-1 awareness.
7) Treatment hesitation.
8) Drop-offs and repeat behaviour.
KOBI does not track obesity as one number.
It tracks obesity as a moving decision landscape.
How you can use KOBI.
KOBI Pulse
Fast obesity-related dipsticks for quick decisions.
KOBI Sprint
Short-cycle studies around one business question.
KOBI Deep Dive
Detailed intelligence across consumers, patients, doctors, and experts.
KOBI Briefing
Sharp leadership briefings for strategy, marketing, product, and therapy teams.
Why KOBI
KOBI is not a generic research service with an obesity page.
It is a dedicated obesity intelligence layer for India.
Proof Points
Obesity-specific.
India-first.
Human-led.
Decision-grade.
Built by Krea eKnowledge.
Designed for business and healthcare decisions.
Quick Dips
Small studies. Sharp signals. Fast decisions.
Check out recent KOBI dipstick studies on obesity, protein,
GLP-1, weight-care behaviour, and health product trust.
View Quick Dips
Run Your Own Quick Check
Obesity: The India Insight Podcast Series.
India at 100 Kilos. What can we do about it?
KOBI brings together doctors, nutritionists, fitness professionals, behaviour specialists, healthcare leaders, and patient-facing voices to understand India’s obesity challenge one sharp conversation at a time.
If obesity in India matters to your business, talk to KOBI.
Whether you are launching a D2C health product, shaping a pharma strategy, building a healthcare service, or trying to understand India’s weight-care market, KOBI helps you make better decisions.
